News

Eli Lilly: Analyzing the Latest Trends in Options Trading

Eli Lilly: Analyzing the Latest Trends in Options Trading

Understanding Eli Lilly's Recent Options Market Dynamics

In an interesting turn of events, Eli Lilly has captured the attention of financial analysts and traders alike. Recent analysis of the options history for Eli Lilly (LLY) indicates that 43 unusual trades have emerged, pointing to a notable shift in market sentiment.

Diving deeper into these trades, we found that 44% of traders exhibited a bullish attitude towards Eli Lilly, while 32% leaned bearish. Among the trades identified, 6 were puts valued at $336,908 and a substantial 37 were calls worth a remarkable $4,614,623.

What Are Expert Price Targets?

The latest trading activities suggest that prominent investors are eyeing a price range between $450.0 and $1040.0 for Eli Lilly in the upcoming months. This range highlights the diverse opinions regarding the stock's future direction.

Analyzing Volume and Open Interest

Currently, the average open interest for Eli Lilly options stands at 350.29, with a total trading volume of 1,947.00. The accompanying analysis charts showcase the trends in both call and put options, as well as the open interest, all situated within the strike price corridor of $450.0 to $1040.0 for the past 30 days, illustrating the evolving landscape of options trading.

Last Month's Options Activity Breakdown

In the last month, significant data has emerged from Eli Lilly's options activity.

Notable Options Trades Recently Identified:

Let’s take a look at some of the most significant options trades detected recently:

  • Symbol: LLY, Type: CALL, Trade Type: SWEEP, Sentiment: BULLISH, Exp. Date: 01/17/25, Strike Price: $500.00, Total Price: $2.8M, Volume: 140
  • Symbol: LLY, Type: CALL, Trade Type: TRADE, Sentiment: BEARISH, Exp. Date: 02/21/25, Strike Price: $900.00, Total Price: $163.7K, Volume: 21
  • Symbol: LLY, Type: CALL, Trade Type: TRADE, Sentiment: BULLISH, Exp. Date: 12/20/24, Strike Price: $1020.00, Total Price: $122.7K, Volume: 312
  • Symbol: LLY, Type: PUT, Trade Type: SWEEP, Sentiment: BULLISH, Exp. Date: 11/08/24, Strike Price: $900.00, Total Price: $102.1K, Volume: 33
  • Symbol: LLY, Type: CALL, Trade Type: SWEEP, Sentiment: BEARISH, Exp. Date: 11/01/24, Strike Price: $700.00, Total Price: $82.2K, Volume: 4

A Closer Look at Eli Lilly

Eli Lilly stands out as a prominent player in the biotechnology sector, focusing on areas such as neuroscience, cardiometabolic conditions, oncology, and immunology. Key products from Eli Lilly include Verzenio for cancer treatment; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for managing cardiovascular health; and Taltz and Olumiant for treating autoimmune diseases.

Given the recent trading activity surrounding Eli Lilly, it's vital to assess its current standing in the market.

Current Insights on Eli Lilly's Position

  • Currently trading at $906.86 with a volume of 454,406, LLY has seen an increase of 1.26%.
  • Relative Strength Indicator (RSI) suggests that the stock may be nearing overbought territory.
  • Upcoming earnings reports are anticipated within a day.

Expert Insights on Eli Lilly

Recently, four industry analysts evaluated Eli Lilly and proposed an average price target of $1102.0, reflecting confidence in the company’s market position.

Tracking Unusual Options Activity: A Guide for Investors

Investors today must remain vigilant, especially with unusual options activity signaling potential market movements. By being alert to significant trades, savvy traders can stay one step ahead of market trends.

For those wishing to delve deeper into real-time alerts regarding Eli Lilly's options trades, it’s beneficial to follow relevant updates to adapt trading strategies that align with market changes.

Frequently Asked Questions

What type of options trades has Eli Lilly seen recently?

Recently, Eli Lilly has experienced unusual bullish and bearish options trades indicating varied market sentiment.

What price range are investors targeting for Eli Lilly?

Investors are targeting a price range between $450.0 and $1040.0 for Eli Lilly based on recent trading activity.

How is Eli Lilly performing in the market currently?

Eli Lilly has seen a stock price increase of 1.26%, currently trading at $906.86 with strong trading volume.

What products does Eli Lilly offer?

Eli Lilly offers a variety of products focusing on cancer, cardiometabolic health, and immunology, including Verzenio, Mounjaro, and Trulicity.

How many analysts are covering Eli Lilly?

Currently, four industry analysts are covering Eli Lilly, providing an average target price of $1102.0.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Oak Farms Invests in Texas Schools and Students

Updated Category News Views 5

Putting Money Where Their Roots Are You have to hand it to Oak Farms; when they say they're rooted in Texas, they actually back it up with some cold, hard cash. They've lined up $27,500 for schools and students across the state. That's the kind of talking I like to see—straight from the brand to the community ledger. No fluff, just good old-fashioned giving in the form...

Continue Reading
National Solar Tour 2026: Discover Solar Power Live

Updated Category News Views 2

Experience Real-Life Solar Innovations It's always worth raising an eyebrow when a grassroots event, that's been kicking around for over three decades, rolls around just waving at us to take part. The National Solar Tour 2026 is crash-landing this weekend, October 2-4, like clockwork, bringing solar tech right to your front porch, figuratively and literally speaking. Get...

Continue Reading
Teamsters Triumph: Court Backs Workers' Health Benefits

Updated Category News Views 4

Court Orders Health Coverage Amid Creamery Dispute Good grief! Just when you think you've seen all the punches the corporate world can throw, something like this comes along. The court's declaration that Dairy Farmers of America (DFA) must keep providing health care to members of Teamsters Local 597 is pushing back the tides for workers at the St. Albans Creamery. This...

Continue Reading
Sarwant Singh Propels Frost & Sullivan's AI Ambitions

Updated Category News Views 4

A Veteran Strategist Returns to the Fold Sharp moves in the corporate world don't always grab headlines, but sometimes you’ve got to stop and consider the buzzworthy comebacks. Keep your eyes peeled for Sarwant Singh's return to Frost & Sullivan, a noteworthy shift that’s shaping the landscape of digital strategies and beyond. Turning Up the Heat on Digital Innovation...

Continue Reading
Survey Says 92% Report Better Life Post-Rehab

Updated Category News Views 4

92% Say Life Improves After TranquilHearts' Treatment It's not every day you see 92% of folks claiming something actually worked for them, huh? That's exactly the kind of figure TranquilHearts Rehab's alumni claimed in their recent survey about improved quality of life post-treatment. But let's not get ahead of ourselves with high-fives and celebration just yet. Here's...

Continue Reading
El Mansouri Becomes Morocco's First Female PM

Updated Category News Views 5

Breaking Barriers: El Mansouri's Historic Appointment Fatima Ezzahra El Mansouri is now steering the ship as Morocco's first female Prime Minister, a milestone that's taken far too long to reach. After the dust settled from the September 23 legislative elections, El Mansouri emerged from the Authenticity and Modernity Party (PAM) with 97 seats in tow. It's a pivotal...

Continue Reading
Bryan Park's Vision Drives Footprints' Surging Growth

Updated Category News Views 5

An Airman’s Mission of Building Legacies When you think of flooring, 'admired CEOs' probably don’t top the list. Yet here’s Bryan Park, an ex-Air Force veteran, shaking things up and earning a nod from the Denver Business Journal. Named one of the Most Admired CEOs of 2026, Park has taken what began as a small flooring operation and turned it into a national...

Continue Reading
Skiptown Expands into Austin: A New Pet Care Frontier

Updated Category News Views 4

Skiptown Marches into the Heart of Texas A move into Texas? Now that's got potential written all over it. Skiptown's making waves by dropping anchor in Austin with a five-unit franchise agreement. We're talking modern dog daycare and more, right in the heart of Central Texas. First up, fall 2027 is when you can circle the calendar. Expect to see more locations sprout up...

Continue Reading
Kohler's Golf Innovation: No Tees Tour Comes Alive

Updated Category News Views 4

Golf Reinvented: Kohler Hosts No Tees Tour Talk about flipping the script, eh? Kohler's teaming up with the No Tees Tour to host an innovative golfing showdown at The Baths of Blackwolf Run, starting October 1. This isn't your grandpa's golf tour. We're talking fast-paced, head-to-head chipping duels that ditch the long drives for surgical precision. The idea's inspired...

Continue Reading
Ontario Fuels Life Sciences Growth with $1.7M Boost

Updated Category News Views 5

A Jolt for Ontario's Life Sciences Sector Ah, there's fresh energy in the air up north, folks. Ontario's dishing out a solid $1.7 million to give Piramal Pharma Solutions' Aurora facility a serious facelift. This isn't just about shiny new labs. It's about staking a claim, saying, "We're serious players on the global stage." They're not just upgrading infrastructure...

Continue Reading

Top 5 Most Recently Viewed Articles

Monte Rosa's New Licensing Deal with Novartis: A Game Changer

Updated Category News Views 234

Monte Rosa Therapeutics Expands Capabilities with Novartis Collaboration BOSTON — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a pioneering biotechnology company on the front lines of developing molecular glue degrader (MGD) therapies, has made significant strides in its mission. Recently, Monte Rosa finalized a global license agreement with Novartis, aimed at...

Continue Reading
Rosen Law Firm Investigates Claims Against Immutable's IMX Tokens

Updated Category News Views 134

Rosen Law Firm Launches Investigation into Immutable's IMX Tokens Rosen Law Firm, recognized for its commitment to investor rights, is currently investigating potential securities claims against Immutable. This investigation arises from serious allegations that Immutable may have provided materially misleading information about its business practices, particularly...

Continue Reading
Circulate Health Secures $12 Million for Longevity Innovations

Updated Category News Views 248

Circulate Health Secures $12 Million for Longevity Innovations In a significant step forward in the field of longevity, Circulate Health has successfully raised $12 million in seed funding. This financing is primarily led by Khosla Ventures and marks a pivotal moment for the company as it continues its mission to harness the potential of therapeutic plasma exchange (TPE)...

Continue Reading
Investors Urged for Wolfspeed, Inc. Class Action Guidance

Updated Category News Views 231

Understanding the Importance of Seeking Legal Counsel for Wolfspeed, Inc. Investors If you've invested in Wolfspeed, Inc., it's crucial to be aware of your rights and the actions you can take, especially if you've incurred losses over $100,000. The law firm Rosen Law Firm is encouraging investors to act swiftly as there is an important deadline approaching. This article...

Continue Reading
Outset Medical Secures $169 Million Financing for Dialysis Innovation

Updated Category News Views 285

Outset Medical Secures Financing to Enhance Dialysis Solutions Outset Medical, Inc. (NASDAQ: OM), a pioneering medical technology company, has successfully entered into a significant financing agreement that stands to transform dialysis care. With a private placement expected to generate approximately $169 million, the company is poised to leverage these funds to expand...

Continue Reading